Alkermes (ALKS) Net Income (2010 - 2026)
Alkermes' (ALKS) quarterly Net Income came in at $524000.0 in Q2 2026, down 99.4% year-over-year from $87.1 million in Q2 2025, and up 100.79% quarter-over-quarter from -$66.5 million in Q1 2026.
Analysis
Alkermes (ALKS) Net Income (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Net Income for 17 consecutive years, with $524000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Income fell 99.4% year-over-year to $524000.0 in Q2 2026; TTM through Jun 2026 was $66.1 million, a 81.04% decrease from a year earlier, with the FY2025 full-year figure at $241.7 million, down 34.03% from the prior year.
- Net Income was $524000.0 for Q2 2026 at Alkermes, up from -$66.5 million in the prior quarter.
- Over five years, Net Income peaked at $237.0 million in Q2 2023 and troughed at -$66.5 million in Q1 2026.
- A 5-year average of $47.4 million and a median of $47.8 million in 2023 frame the typical range for Net Income.
- Across the five-year window, Net Income slumped 1374.79% in 2022 and soared 886.52% in 2023, its largest moves.
- Over 5 years, Net Income stood at $87.7 million in 2022, then surged by 36.46% to $119.7 million in 2023, then increased by 22.73% to $146.9 million in 2024, then slumped by 66.38% to $49.4 million in 2025, then tumbled by 98.94% to $524000.0 in 2026.
- The last three Net Income figures came in at $524000.0 (Q2 2026), -$66.5 million (Q1 2026), and $49.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.93 Bn | 625.17 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 443.06 Bn | 436.49 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 365.76 Bn | 358.62 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 266.47 Bn | 258.78 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -238.00 Mn |
| 6 | Sanofi | 52.36 Bn | 44.98 Bn | 10.79 Bn | 2.16 Bn |
| 7 | Revolution Medicines | 43.97 Bn | 43.97 Bn | - | -644.37 Mn |
| 8 | Incyte | 25.42 Bn | 20.88 Bn | 1.57 Bn | 585.61 Mn |
| 9 | United Therapeutics | 21.52 Bn | 18.86 Bn | 683.80 Mn | 333.00 Mn |
| 10 | Alkermes | 7.58 Bn | 6.93 Bn | 397.90 Mn | 524,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 524,000.00 |
| Mar 31, 2026 | -66.53 Mn |
| Dec 31, 2025 | 49.39 Mn |
| Sep 30, 2025 | 82.75 Mn |
| Jun 30, 2025 | 87.10 Mn |
| Mar 31, 2025 | 22.46 Mn |
| Dec 31, 2024 | 146.90 Mn |
| Sep 30, 2024 | 92.31 Mn |
| Jun 30, 2024 | 90.71 Mn |
| Mar 31, 2024 | 36.40 Mn |
| Dec 31, 2023 | 119.70 Mn |
| Sep 30, 2023 | 46.16 Mn |
| Jun 30, 2023 | 237.03 Mn |
| Mar 31, 2023 | -48.57 Mn |
| Dec 31, 2022 | 87.72 Mn |
| Sep 30, 2022 | -63.97 Mn |
| Jun 30, 2022 | -30.14 Mn |
| Mar 31, 2022 | -35.90 Mn |
| Dec 31, 2021 | 125.44 Mn |
| Sep 30, 2021 | -28.99 Mn |